Literature DB >> 23119457

Surgery in early cancer of the oral tongue (Tl-2). Wide excision versus hemiglossectomy.

H K Parikh1, R S Rao, P Sukhthankar, V H Deshmane, D M Parikh.   

Abstract

Cancer of the oral tongue is a common disease. Thirty five (35%) percent of patients seen at our hospital are in Stages I&II. The choice of surgical treatment is a wide excision of the lesion (WE) or a hemiglossectomy (HG). This study was carried out to compare the local recu-rrences and survival in patients undergoing either a WE or HG for early cancer of the tongue. One hundred and twenty six (126) patients were evaluated, 40 underwent a WE and 86 HG. The local recurrence was higher in the WE group, 25% compared with 9% in the HG group; which is statistically significant (p=0.02). This was also seen in the Tl subgroup (p=0.003). Survival were better in the HG group (p=0.005), which was also seen for the Tl subgroup (p=0.004). Our study demonstrates that there is a lower incidence of local recurrences following a hemiglossectomy for Tl-2 tumours of the oral tongue with improved survivals. Our recommendation is that hemi-glossectomy should be the optimal surgery performed for early cancer of the oral tongue.

Entities:  

Keywords:  Hemiglossectomy; Squamous carcinoma; Tongue; Wide Excision

Year:  1998        PMID: 23119457      PMCID: PMC3451420          DOI: 10.1007/BF03000686

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  7 in total

1.  Median labiomandibular glossotomy. Trotter's median (anterior) translingual pharyngotomy.

Authors:  H MARTIN; H R TOLLEFSEN; F P GEROLD
Journal:  Am J Surg       Date:  1961-12       Impact factor: 2.565

2.  Epidermoid carcinoma of the mobile tongue. Treatment by partial glossectomy alone.

Authors:  R H Spiro; E W Strong
Journal:  Am J Surg       Date:  1971-12       Impact factor: 2.565

3.  Elective versus therapeutic neck dissection in early carcinoma of the oral tongue.

Authors:  A R Fakih; R S Rao; A M Borges; A R Patel
Journal:  Am J Surg       Date:  1989-10       Impact factor: 2.565

4.  Improved survival in the treatment of squamous carcinoma of the oral tongue.

Authors:  D Franceschi; R Gupta; R H Spiro; J P Shah
Journal:  Am J Surg       Date:  1993-10       Impact factor: 2.565

5.  Treatment of stage I and II oral tongue cancer.

Authors:  D D Lydiatt; K T Robbins; R M Byers; P F Wolf
Journal:  Head Neck       Date:  1993 Jul-Aug       Impact factor: 3.147

6.  Results of cesium needle interstitial implantation for carcinoma of the oral tongue.

Authors:  M Hareyama; M Nishio; A Saito; Y Kagami; K Asano; A Oouchi; N Narimatsu; Y Somekawa; S Sanbe; K Morita
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-01       Impact factor: 7.038

7.  Experience of the Curie Institute in treatment of cancer of the mobile tongue: I. Treatment policies and result.

Authors:  Y Decroix; N A Ghossein
Journal:  Cancer       Date:  1981-02-01       Impact factor: 6.860

  7 in total
  2 in total

Review 1.  Post-glossectomy in lingual carcinomas: a scope for sign language in rehabilitation.

Authors:  Arvind Babu Rajendra Santosh; Keren Cumberbatch; Thaon Jones
Journal:  Contemp Oncol (Pozn)       Date:  2017-06-30

2.  Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer.

Authors:  Mahadev Potharaju; Hemanth Raj E; Manavalan Muthukumaran; Murali Venkataraman; Bhargavi Ilangovan; Selvan Kuppusamy
Journal:  J Contemp Brachytherapy       Date:  2018-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.